
| Time | Agenda Item | Speaker |
|---|---|---|
| 08:30 – 09:00 | Registration | |
| 09:00 – 09:10 | Welcome and Opening Remarks | Dr. Salha Bujassoum Chair of Medical Oncology and Palliative Care, Senior Consultant Medical Oncologist, NCCCR |
| 09:10 – 09:15 | Session 1: Lung Cancer | Chairperson: Dr. Reyad Mohsen Senior Consultant Medical Oncologist, NCCCR |
| 09:15 – 09:35 | Surgical Outcomes With Checkpoint Inhibitors in Resectable NSCLC | Dr. Ehab Masaad Senior Consultant in Thoracic Surgery – HMC |
| 09:35 – 09:55 | Redefining Survival: Long-Term Outcomes in mNSCLC with Checkpoint Inhibitors | Dr. Alaa Kanbour Consultant Medical Oncologist, NCCCR |
| 09:55 – 10:05 | Panel Discussion | |
| 10:05 – 10:10 | Session 2: GU Cancers | Chairperson: Dr. Mohammed Usama Al Homsi Deputy Medical Director for Education, Research and Quality, Senior Consultant Medical Oncologist, NCCCR |
| 10:10 – 10:30 | Enhancing Treatment outcomes in localized and advanced RCC | Dr. Abdulrehman Zar Gul Senior Consultant Medical Oncologist, NCCCR |
| 10:30 – 10:50 | The current standard of care for advanced urothelial cancer | Dr. Ammar Madani Associate Consultant Medical Oncologist, NCCCR |
| 10:50 – 11:00 | Panel Discussion | |
| 11:00 – 11:15 | Coffee Break |